M.D., Associate Chief Physician Specializes in the diagnosis and treatment of chronic hepatitis B, the prevention and management of hepatitis B recurrence after liver transplantation, and perioperative medical treatment for liver transplantation. Research Achievements Published 14 papers as the first author, including 10 SCI papers. Among them, research findings on the antiviral efficacy of entecavir in liver transplant patients have been cited by the German Guidelines for the Diagnosis and Treatment of Liver Diseases, Schiff's Diseases of the Liver, and the American textbook Clinical Gastroenterology and Hepatology. An article on the prevention and treatment of hepatitis B after surgery in children receiving living donor liver transplantation from hepatitis B-negative patients who received core antibody-positive donors has been cited by the American Guidelines for the Management of Hepatitis B-Positive Donor and Recipient After Surgery. Research Direction Prevention and treatment of hepatitis B recurrence after liver transplantation, research on the mechanisms of liver tumor development and progression Personal Honors As the sixth contributor, received the First Prize of the Science and Technology Progress Award of the Ministry of Education of China in 2014 and the First Prize of the Huaxia Medical Science and Technology Award. As the ninth contributor, received the First Prize of the Shanghai Science and Technology Progress Award in 2015. Awarded the title of "March 8th Red Banner Pacesetter" by Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine in 2023.